Haisco Pharmaceutical Group Co.,Ltd — Investor Relations & Filings
Haisco Pharmaceutical Group Co.,Ltd. focuses on the research, development, production, and commercialization of innovative drugs and high-end generic pharmaceuticals. The company maintains a specialized portfolio across therapeutic areas including anesthesia, parenteral nutrition, anti-infection, cardiovascular health, and endocrine disorders. Key products include advanced anesthetic agents and specialized nutritional injections designed for clinical use. Haisco prioritizes technological innovation through a dedicated R&D infrastructure, targeting the development of small molecule chemical drugs and complex delivery systems. Its operations emphasize high-standard manufacturing processes and the integration of clinical research to address complex medical requirements. The company aims to provide therapeutic solutions that enhance patient care through a commitment to scientific excellence and product quality.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于部分5%以上股东之一致行动人减持股份触及1%整数倍的公告 | 2026-03-09 | Chinese | |
| 关于获得创新药HSK39297片上市许可《受理通知书》的公告 | 2026-03-08 | Chinese | |
| 关于获得创新药HSK50042片新增适应症《药物临床试验批准通知书》的公告 | 2026-03-05 | Chinese | |
| 关于共同投资设立子公司暨关联交易的公告 | 2026-02-12 | Chinese | |
| 第五届董事会第三十六次会议决议公告 | 2026-02-12 | Chinese | |
| 关于变更2025年度向特定对象发行A股股票项目保荐代表人的公告 | 2026-02-12 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 36673074 | 关于部分5%以上股东之一致行动人减持股份触及1%整数倍的公告 | 2026-03-09 | Chinese | ||
| 36673072 | 关于获得创新药HSK39297片上市许可《受理通知书》的公告 | 2026-03-08 | Chinese | ||
| 36673066 | 关于获得创新药HSK50042片新增适应症《药物临床试验批准通知书》的公告 | 2026-03-05 | Chinese | ||
| 36673065 | 关于共同投资设立子公司暨关联交易的公告 | 2026-02-12 | Chinese | ||
| 36673063 | 第五届董事会第三十六次会议决议公告 | 2026-02-12 | Chinese | ||
| 36673057 | 关于变更2025年度向特定对象发行A股股票项目保荐代表人的公告 | 2026-02-12 | Chinese | ||
| 36673054 | 关于部分5%以上股东之一致行动人股份减持计划的预披露公告 | 2026-02-02 | Chinese | ||
| 36673048 | 北京市中伦（深圳）律师事务所关于海思科医药集团股份有限公司2026年第一次临时股东会的法律意见书 | 2026-01-28 | Chinese | ||
| 36673046 | 2026年第一次临时股东会决议公告 | 2026-01-28 | Chinese | ||
| 36673041 | 2025年度向特定对象发行A股股票募集说明书（注册稿） | 2026-01-16 | Chinese | ||
| 36672967 | 关于向特定对象发行股票申请获得中国证监会同意注册批复的公告 | 2026-01-16 | Chinese | ||
| 36672965 | 公司章程（2026年1月） | 2026-01-16 | Chinese | ||
| 36672962 | 关于修订《公司章程》的公告 | 2026-01-16 | Chinese | ||
| 36672955 | 关于2026年第一次临时股东会增加临时提案并取消部分议案暨召开2026年第一次临时股东会补充通知的公告 | 2026-01-16 | Chinese | ||
| 36672953 | 第五届董事会第三十五次会议决议公告 | 2026-01-16 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Haisco Pharmaceutical Group Co.,Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/54674/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=54674 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=54674 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=54674 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 54674}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Haisco Pharmaceutical Group Co.,Ltd (id: 54674)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.